Virological features of hepatitis B virus-associated nephropathy in Japan

Journal of Medical Virology

Volumn 79, Issue 9, 2007, Pages 1305-1311

  Kusakabe, Atsunori ^a   Tanaka, Yasuhito ^a   Kurbanov, Fuat ^a   Goto, Kenji ^a   Tajiri, Hitoshi ^b   Murakami, Jun ^c   Okuse, Chiaki ^d   Yotsuyanagi, Hiroshi ^e   Joh, Takashi ^a   Mizokami, Masashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Genotype; Hepatitis B virus; Nephropathy; Viral mutation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; PHENYLALANINE; VALINE; VIRUS DNA;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENE DELETION; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; JAPAN; KIDNEY DISEASE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; VIRUS CELL INTERACTION; VIRUS MUTATION; VIRUS TYPING;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; CONSENSUS SEQUENCE; GENOTYPE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; JAPAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY;

HEPATITIS B VIRUS;

EID: 34547110353     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20941     Document Type: Article

References (37)

1. Bhimma R, Coovadia HM, Adhikari M. 1998. Hepatitis B virus-associated nephropathy in black South African children. Pediatr Nephrol 12:479-484.
2. Bhimma R, Coovadia HM, Kramvis A, Adhikari M, Kew MC. 2002a. Treatment of hepatitis B virus-associated nephropathy in black children. Pediatr Nephrol 17:393-399.
3. Bhimma R, Coovadia M, Hammond MG, Kramvis A, Adhikari M, Kew MC. 2002b. HLA associations with HBV carriage and proteinuria. Pediatr Nephrol 17:724-729.
4. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ. 2004. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53:1494-1498.
5. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. 2006. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130: 1153-1168.
6. Combes RB. 1971. John: A psychiatric patient. Nurs Mirror Midwives J 133:32-33 passim.
7. Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM. 1995. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 109:540-546.
8. Connor FL, Rosenberg AR, Kennedy SE, Bohane TD. 2003. HBV associated nephrotic syndrome: Resolution with oral lamivudine. Arch Dis Child 88:446-449.
9. Couser WG, Abrass CK. 1988. Pathogenesis of membranous nephropathy. Annu Rev Med 39:517-530.
10. de Man RA, Schalm SW, van der Heijden AJ, ten Kate FW, Wolff ED, Heijtink RA. 1989. Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy. J Hepatol 8:367-372.
11. Filler G, Feber J, Weiler G, Le Saux N. 2003. Another case of HBV associated membranous glomerulonephritis resolving on lamivudine. Arch Dis Child 88:460.
12. Garcia G, Scullard G, Smith C, Weissberg J, Alexander S, Robinson WS, Gregory P, Merigan TC. 1985. Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon. Hepatology 5:317-320.
13. Gilbert RD, Wiggelinkhuizen J. 1994. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 8:11-14.
14. Johnson RJ, Couser WG. 1990. Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37:663-676.
15. Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J. 2005. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-Saharan Africans. J Med Virol 75:513-521.
16. Kim SE, Park YH, Chung WY. 2006. Study on hepatitis B virus pre-S/S gene mutations of renal tissues in children with hepatitis B virus-associated membranous nephropathy. Pediatr Nephrol 21:1097-1103.
17. Kimbi GC, Kramvis A, Kew MC. 2004. Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa. J Gen Virol 85:1211-1220.
18. Kramvis A, Kew M, Francois G. 2005. Hepatitis B virus genotypes. Vaccine 23:2409-2423.
19. Lin CY. 1995. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 47: 225-230.
20. Lisker-Melman M, Webb D, Di Bisceglie AM, Kassianides C, Martin P, Rustgi V, Waggoner JG, Park Y, Hoofnagle JH. 1989. Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon. Ann Intern Med 111: 479-483.
21. Miyakawa Y, Mizokami M. 2003. Classifying hepatitis B virus genotypes. Intervirology 46:329-338.
22. Mizushima N, Kanai K, Matsuda H, Matsumoto M, Tamakoshi K, Ishii H, Nakajima T, Yoshimi T, Kimura M, Nagase M. 1987. Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon. Gastroenterology 92:524-526.
23. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309.
24. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M. 1988. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J Gen Virol 69:2575-2583.
25. Okuse C, Yotsuyanagi H, Yamada N, Ikeda H, Takahashi H, Suzuki M, Kondo S, Kimura K, Koike J, Itoh F. 2006. Successful treatment of hepatitis B virus-associated membranous nephropathy with lamivudine. Clin Nephrol 65:53-56.
26. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, Okita K, Okanoue T, Iino S, Tanaka E, Suzuki K, Watanabe H, Hige S, Mizokami M. 2001a. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 34:590-594.
27. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, Okanoue T, Yotsuyanagi H, Iino S. 2001b. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 33:218-223.
28. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R. 2000. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J Gen Virol 81: 67-74.
29. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Suzuki S, Kimura Y, Ueda R, Butterworth LA, Cooksley WG. 2001. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: Complete genome sequence and phylogenetic relatedness. J Gen Virol 82:883-892.
30. Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, Ishida T, Chutaputti A, Lai CL, Ueda R, Miyakawa Y, Mizokami M. 2002. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol 76:5985-5992.
31. Sugauchi F, Ohno T, Orito E, Sakugawa H, Ichida T, Komatsu M, Kuramitsu T, Ueda R, Miyakawa Y, Mizokami M. 2003a. Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol 70:537-544.
32. Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, Ishida T, Chutaputti A, Lai CL, Gish RG, Ueda R, Miyakawa Y, Mizokami M. 2003b. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology 124:925-932.
33. Sugauchi F, Kumada H, Acharya SA, Shrestha SM, Gamutan MT, Khan M, Gish RG, Tanaka Y, Kato T, Orito E, Ueda R, Miyakawa Y, Mizokami M. 2004. Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. J Gen Virol 85:811-820.
34. Takekoshi Y, Tanaka M, Miyakawa Y, Yoshizawa H, Takahashi K, Mayumi M. 1979. Free "small" and IgG-associated "large" hepatitis B e antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Engl J Med 300:814-819.
35. Tanaka Y, Hasegawa I, Kato T, Orito E, Hirashima N, Acharya SK, Gish RG, Kramvis A, Kew MC, Yoshihara N, Shrestha SM, Khan M, Miyakawa Y, Mizokami M. 2004. A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 40:747-755.
36. Tanaka Y, Orito E, Yuen MF, Mukaide M, Sugauchi F, Ito K, Ozasa A, Sakamoto T, Kurbanov F, Lai CL, Mizokami M. 2005. Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism. Hepatol Res 33:216-224.
37. Wong SN, Yu EC, Lok AS, Chan KW, Lau YL. 1992. Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Pediatr Nephrol 6:417-420.